Amoxicillin Potassium Clavulanate Tablets IP, 625 mg

₹ 2,017/Box

Strength625 mg
FormTablets
Packaging typeBox
Pack Size10x10 Tablets
Item NameMOXYNOV-CV 625
UsageTo treat many different infections
BrandNovo Lilly
AvailabilityIn Stock
Amoxicillin and clavulanate potassium is a combination medicine used to treat many different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin.

Find products similar to Amoxicillin Potassium Clavulanate Tablets IP, 625 Mg

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Product Image

Amoxicillin Potassium Clavulanate Tablets IP, 625 mg-1Amoxicillin Potassium Clavulanate Tablets IP, 625 mg-2Amoxicillin Potassium Clavulanate Tablets IP, 625 mg-3Amoxicillin Potassium Clavulanate Tablets IP, 625 mg-4Amoxicillin Potassium Clavulanate Tablets IP, 625 mg-5Amoxicillin Potassium Clavulanate Tablets IP, 625 mg-6Amoxicillin Potassium Clavulanate Tablets IP, 625 mg-7

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
06-07-2021
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Feb 2021
GST
06AAHCN6355M1ZZ
Established as a Pvt.Limited Company firm in the year 2021, we “Novolilly Pharmaceutical Private Limited” are a leading Wholesale Trader, Retailer and distributor of a wide range of Pharmaceutical Tablets, Pharmaceutical Suspension, Massage Oil, etc.
We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.For our accomplishment story, we are grateful to Our CEO Gomeda Bansal whose continual backing and direction have been useful to us for attaining exponential development in the current market